NCT05366439View on ClinicalTrials.gov

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions
Dengue
Interventions
DRUG

AT-752

Parallel Assignment

DRUG

Placebo Comparator

Parallel Assignment

Trial Locations (1)

13215

Atea Study Site, Syracuse

Sponsors
All Listed Sponsors
lead

Atea Pharmaceuticals, Inc.

INDUSTRY

NCT05366439 - Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model | Biotech Hunter | Biotech Hunter